Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-25 @ 4:02 PM
NCT ID: NCT01812057
Description: Adverse Event reporting for this study were limited to surgical site infections and wound dehiscence assessed by the obstetricians daily
Frequency Threshold: 0
Time Frame: Adverse Events were collected from the time PACU admission until 48 hours from PACU admission.
Study: NCT01812057
Study Brief: Dexamethasone for Post-cesarean Delivery Pain
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dexamethasone Dexamethasone 8 mg IV given intraoperatively as a one-time dose. Dexamethasone: Dexamethasone 8 mg IV (as a one time dose) None None 0 23 0 23 View
Placebo Sodium chloride 0.9% (5 ml) given IV intraoperatively as a one time dose. Placebo: Sodium Chloride 0.9% -5 ml None None 0 24 0 24 View
Serious Events(If Any):
Other Events(If Any):